Dual targeting of l-carnitine-conjugated nanoparticles to OCTN2 and ATB^0,+ to deliver chemotherapeutic agents for colon cancer therapy

References

• Bhutia YD, Babu E, Prasad PD, Ganapathy V. (2014). The amino acid transporter SLC6A14 in cancer and its potential use in chemotherapy. Asian J Pharm Sci 9:293–303.
   Google Scholar
• Bowerman CJ, Byrne JD, Chu KS, et al. (2017). Docetaxel-loaded PLGA nanoparticles improve efficacy in taxane-resistant triple-negative breast cancer. Nano Lett 17:242–8.
   PubMed Web of Science ®Google Scholar
• Breslin S, O’driscoll L. (2013). Three-dimensional cell culture: the missing link in drug discovery. Drug Discov Today 18:240–9.
   PubMed Web of Science ®Google Scholar
• Calcagno AM, Ludwig JA, Fostel JM, et al. (2006). Comparison of drug transporter levels in normal colon, colon cancer, and Caco-2 cells: impact on drug disposition and discovery. Mol Pharmaceutics 3:87–93.
   PubMed Web of Science ®Google Scholar
• Campos J, Varasgodoy M, Haidar ZS. (2017). Physicochemical characterization of chitosan-hyaluronan-coated solid lipid nanoparticles for the targeted delivery of paclitaxel: a proof-of-concept study in breast cancer cells. Nanomedicine 12:473–90.
   PubMed Web of Science ®Google Scholar
• Chabner BA, Roberts TG. (2005). Timeline: chemotherapy and the war on cancer. Nat Rev Cancer 5:65–72.
   PubMed Web of Science ®Google Scholar
• Chandolu V, Dass CR. (2013). Treatment of lung cancer using nanoparticle drug delivery systems. Curr Drug Discov Technol 10:170–6.
   PubMedGoogle Scholar
• Chen W, Zheng R, Baade PD, et al. (2016). Cancer statistics in China, 2015. CA Cancer J Clin 66:115–32.
   PubMed Web of Science ®Google Scholar
• Cisterna BA, Kamaly N, Choi WI, et al. (2016). Targeted nanoparticles for colorectal cancer. Nanomedicine (Lond) 11:2443–56.
   PubMed Web of Science ®Google Scholar
• Cocco E, Deng Y, Shapiro EM, et al. (2016). Dual-targeting nanoparticles for in vivo delivery of suicide genes to chemotherapy-resistant ovarian cancer cells. Mol Cancer Ther 16:323–33.
   PubMed Web of Science ®Google Scholar
• Compton CC, Byrd DR, Garcia-Aguilar J, et al. 2012. Colon and rectum. AJCC cancer staging atlas. New York (NY): Springer, 185–201.
   Google Scholar
• Cortez C, Tomaskovic-Crook E, Johnston AP, et al. (2007). Influence of size, surface, cell line, and kinetic properties on the specific binding of A33 antigen-targeted multilayered particles and capsules to colorectal cancer cells. ACS Nano 1:93–102.
   PubMed Web of Science ®Google Scholar
• Couvreur P. (2013). Nanoparticles in drug delivery: past, present and future. Adv Drug Deliv Rev 65:21–3.
   PubMed Web of Science ®Google Scholar
• Dai Z, Yao Q, Zhu L. (2016). MMP2-sensitive PEG–lipid copolymers: a new type of tumor-targeted P-glycoprotein inhibitor. ACS Appl Mater Interfaces 8:12661–73.
   PubMed Web of Science ®Google Scholar
• Fasehee H, Dinarvand R, Ghavamzadeh A, et al. (2016). Delivery of disulfiram into breast cancer cells using folate-receptor-targeted PLGA-PEG nanoparticles: in vitro and in vivo investigations. J Nanobiotechnol 14:32.
   PubMed Web of Science ®Google Scholar
• Friedrich J, Seidel C, Ebner R, Kunz-Schughart LA. (2009). Spheroid-based drug screen: considerations and practical approach. Nat Protoc 4:309–24.
   PubMed Web of Science ®Google Scholar
• Fujiya M, Inaba Y, Musch MW, et al. (2011). Cytokine regulation of OCTN2 expression and activity in small and large intestine. Inflamm Bowel Dis 17:907–16.
   PubMed Web of Science ®Google Scholar
• Ganapathy V, Thangaraju M, Prasad PD. (2015). Nutrient transporters in cancer: relevance to Warburg hypothesis and beyond. Pharmacol Ther 121:29–40.
   Web of Science ®Google Scholar
• Gupta N, Miyauchi S, Martindale RG, et al. (2005). Upregulation of the amino acid transporter ATB 0,+ (SLC6A14) in colorectal cancer and metastasis in humans. Biochim Biophys Acta, Mol Basis Dis 1741:215–23.
   PubMed Web of Science ®Google Scholar
• Hatanaka T, Haramura M, Fei Y-J, et al. (2004). Transport of amino acid-based prodrugs by the Na+-and Cl–coupled amino acid transporter ATB0,+ and expression of the transporter in tissues amenable for drug delivery. J Pharmacol Exp Ther 308:1138–47.
   PubMed Web of Science ®Google Scholar
• Hayashi T, Onodera R, Tahara K, Takeuchi H. (2016). Novel approaches for posterior segment ocular drug delivery with folate-modified liposomal formulation. Asian J Pharm Sci 11:201–2.
   Google Scholar
• Hoang B, Ernsting MJ, Murakami M, et al. (2014). Docetaxel-carboxymethylcellulose nanoparticles display enhanced anti-tumor activity in murine models of castration-resistant prostate cancer. Int J Pharm 471:224–33.
   PubMed Web of Science ®Google Scholar
• Ishiguro S, Cai S, Uppalapati D, et al. (2016). Intratracheal administration of hyaluronan-cisplatin conjugate nanoparticles significantly attenuates lung cancer growth in mice. Pharm Res 33:2517–29.
   PubMed Web of Science ®Google Scholar
• Kamaly N, Xiao Z, Valencia PM, et al. (2012). ChemInform abstract: targeted polymeric therapeutic nanoparticles: design, development and clinical translation. Chem Soc Rev 43:2971–3010.
   Web of Science ®Google Scholar
• Karra N, Nassar T, Ripin AN, et al. (2013). Antibody conjugated PLGA nanoparticles for targeted delivery of paclitaxel palmitate: efficacy and biofate in a lung cancer mouse model. Small 9:4221–36.
   PubMed Web of Science ®Google Scholar
• Kopansky E, Shamay Y, David A. (2011). Peptide-directed HPMA copolymer-doxorubicin conjugates as targeted therapeutics for colorectal cancer. J Drug Targeting 19:933–43.
   PubMed Web of Science ®Google Scholar
• Kou L, Sun J, Zhai Y, He Z. (2013). The endocytosis and intracellular fate of nanomedicines: implication for rational design. Asian J Pharm Sci 8:1–10.
   Google Scholar
• Kou L, Yao Q, Sun M, et al. (2017). Cotransporting ion is a trigger for cellular endocytosis of transporter-targeting nanoparticles: a case study of high-efficiency SLC22A5 (OCTN2)-mediated carnitine-conjugated nanoparticles for oral delivery of therapeutic drugs. Adv Healthc Mater 6:1700165.
   Web of Science ®Google Scholar
• Li M, Tang Z, Zhang Y, et al. (2015). Targeted delivery of cisplatin by LHRH-peptide conjugated dextran nanoparticles suppresses breast cancer growth and metastasis. Acta Biomater 18:132–43.
   PubMed Web of Science ®Google Scholar
• Li Z, Tao W, Zhang D, et al. (2017). The studies of PLGA nanoparticles loading atorvastatin calcium for oral administration in vitro and in vivo. Asian J Pharm Sci 12:285–91.
   PubMed Web of Science ®Google Scholar
• Lian H, Zhang T, Sun J, et al. (2013). Enhanced oral delivery of paclitaxel using acetylcysteine functionalized chitosan-vitamin E succinate nanomicelles based on a mucus bioadhesion and penetration mechanism. Mol Pharmaceutics 10:3447–58.
   PubMed Web of Science ®Google Scholar
• Li L, Di X, Zhang S, et al. (2016). Large amino acid transporter 1 mediated glutamate modified docetaxel-loaded liposomes for glioma targeting. Colloids Surf B 141:260–7.
   PubMed Web of Science ®Google Scholar
• Li L, Di X, Wu M, et al. (2017). Targeting tumor highly-expressed LAT1 transporter with amino acid-modified nanoparticles: toward a novel active targeting strategy in breast cancer therapy. Nanomedicine 13:987–98.
   PubMed Web of Science ®Google Scholar
• Luo Q, Gong P, Sun M, et al. (2016). Transporter occluded-state conformation-induced endocytosis: amino acid transporter ATB0,+-mediated tumor targeting of liposomes for docetaxel delivery for hepatocarcinoma therapy. J Control Release 243:370–80.
   PubMed Web of Science ®Google Scholar
• Luo Q, Yang B, Tao W, et al. (2017). ATB0,+ transporter-mediated targeting delivery to human lung cancer cells via aspartate-modified docetaxel-loading stealth liposomes. Biomater Sci 5:295–304.
   PubMed Web of Science ®Google Scholar
• Martini M, Ferrara AM, Giachelia M, et al. (2012). Association of the OCTN1/1672T variant with increased risk for colorectal cancer in young individuals and ulcerative colitis patients. Inflamm Bowel Dis 18:439–48.
   PubMed Web of Science ®Google Scholar
• Muro S. (2012). Challenges in design and characterization of ligand-targeted drug delivery systems. J Control Release 164:125–37.
   PubMed Web of Science ®Google Scholar
• Nagesh PKB, Johnson N, Boya VK, et al. (2016). PSMA antibody functionalized docetaxel-loaded magnetic nanoparticles for prostate cancer therapy. AACR 76:1312.
   Web of Science ®Google Scholar
• Nakanishi T, Hatanaka T, Huang W, et al. (2001). Na+- and Cl–-coupled active transport of carnitine by the amino acid transporter ATB(0,+) from mouse colon expressed in HRPE cells and Xenopus oocytes. J Physiol 532:297–304.
   PubMed Web of Science ®Google Scholar
• Perche F, Torchilin VP. (2012). Cancer cell spheroids as a model to evaluate chemotherapy protocols. Cancer Biol Ther 13:1205–13.
   PubMed Web of Science ®Google Scholar
• Perepelyuk M, Maher C, Lakshmikuttyamma A, Shoyele SA. (2016). Aptamer-hybrid nanoparticle bioconjugate efficiently delivers miRNA-29b to non-small-cell lung cancer cells and inhibits growth by downregulating essential oncoproteins. Int J Nanomed 11:3533–44.
   PubMed Web of Science ®Google Scholar
• Pi F, Hui Z, Hui L, et al. (2017). RNA nanoparticles harboring annexin A2 aptamer can target ovarian cancer for tumor-specific doxorubicin delivery. Nanomedicine 13:1183–93.
   PubMed Web of Science ®Google Scholar
• Pochini L, Scalise M, Galluccio M, Indiveri C. (2013). OCTN cation transporters in health and disease: role as drug targets and assay development. J Biomol Screen 18:851–67.
   PubMedGoogle Scholar
• Rebouche CJ, Seim H. (1998). Carnitine metabolism and its regulation in microorganisms and mammals. Annu Rev Nutr 18:39–61.
   PubMed Web of Science ®Google Scholar
• Roberts CM, Shahin SA, Wen W, et al. (2017). Nanoparticle delivery of siRNA against TWIST to reduce drug resistance and tumor growth in ovarian cancer models. Nanomed Nanotechnol Biol Med 13:965–76.
   PubMed Web of Science ®Google Scholar
• Sanna V, Singh CK, Jashari R, et al. (2017). Targeted nanoparticles encapsulating (−)-epigallocatechin-3-gallate for prostate cancer prevention and therapy. Sci Rep 7:41573.
   PubMed Web of Science ®Google Scholar
• Scalise M, Galluccio M, Accardi R, et al. (2012). Human OCTN2 (SLC22A5) is down-regulated in virus- and nonvirus-mediated cancer. Cell Biochem Funct 30:419–25.
   PubMed Web of Science ®Google Scholar
• Shao K, Ding N, Huang S, et al. (2014). Smart nanodevice combined tumor-specific vector with cellular microenvironment-triggered property for highly effective antiglioma therapy. ACS Nano 8:1191–203.
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Jemal A. (2016). Cancer statistics, 2016. CA Cancer J Clin 66:7–30.
   PubMed Web of Science ®Google Scholar
• Sun T, Zhang YS, Pang B, et al. (2015). Engineered nanoparticles for drug delivery in cancer therapy. Angew Chem Int Ed Engl 53:12320–64.
   Web of Science ®Google Scholar
• Tamai I. (2013). Pharmacological and pathophysiological roles of carnitine/organic cation transporters (OCTNs: SLC22A4, SLC22A5 and Slc22a21). Biopharm Drug Dispos 34:29–44.
   PubMed Web of Science ®Google Scholar
• Tiernan J, Perry S, Verghese E, et al. (2013). Carcinoembryonic antigen is the preferred biomarker for in vivo colorectal cancer targeting. Br J Cancer 108:662–7.
   PubMed Web of Science ®Google Scholar
• Tummala S, Kuppusamy G, Satish Kumar M, et al. (2016). 5-Fluorouracil enteric-coated nanoparticles for improved apoptotic activity and therapeutic index in treating colorectal cancer. Drug Deliv 23:2902–10.
   PubMed Web of Science ®Google Scholar
• Vilos C, Morales FA, Solar PA, et al. (2013). Paclitaxel-PHBV nanoparticles and their toxicity to endometrial and primary ovarian cancer cells. Biomaterials 34:4098.
   PubMed Web of Science ®Google Scholar
• Wang M, Sun J, Zhai Y, et al. (2015). Enteric polymer based on pH-responsive aliphatic polycarbonate functionalized with vitamin E to facilitate oral delivery of tacrolimus. Biomacromolecules 16:1179–90.
   PubMed Web of Science ®Google Scholar
• Wu J, Chen Q, Liu W, et al. (2017). Recent advances in microfluidic 3D cellular scaffolds for drug assays. TrAC Trends Anal Chem 87:19–31.
   Web of Science ®Google Scholar